Advertisement

Topics

Sumitomo Corporation of America Company Profile

17:20 EDT 24th September 2017 | BioPortfolio

Sumitomo Corporation of America (SCOA) is a wholly owned subsidiary of Sumitomo Corporation (SC), an integrated trading and investment enterprise engaged in multifaceted business activities, which include selling a variety of domestic products and services, conducting import/ export and trilateral business transactions, providing domestic and international business investment, and participating in numerous other profitable activities facilitated by its global network and the relationships of trust built with corporate business partners and consumers in various industrial sectors around the world. SC's Life Sciences Group has more than 40 years of proven pharmaceutical experience with over $400 million in Pharma sector revenue and 200 experienced professionals strategically located in New York, London, Tokyo, Osaka, Milan, Barcelona, Shanghai and Mumbai. The Group has 10 pharma related affiliate companies, including SPI which conducts total outsourcing from R&D to Commercial Stage. SCOA's Life Sciences Unit provides a gateway for entry into the Japanese marketplace through distribution, licensing and joint ventures. Additionally, SCOA provides financing and venture debt instruments to life sciences companies through its subsidiary Oxford Finance Corporation. Sumitomo's unique positioning and its integrated and complimentary suite of service offerings provides bio venture companies with a opportunity to advance their business models through efficient and rapid penetration into the Japanese and other international markets. SCOA Life Sciences Unit is based in SCOA's New York headquarters. For more information about SCOA, visit www.sumitomocorp.com


News Articles [459 Associated News Articles listed on BioPortfolio]

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report [Report Updated: 02082017] Prices from USD $175

Sumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance ReportSummarySumitomo Dainippon Pharma Co., Ltd. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive co...

Sumitomo Dainippon seeks new indication for PD drug in Japan

Tokyo’s Sumitomo Dainippon Pharma has applied to extend its Japanese marketing authorization for Parkinson’s…

Savaria Announces Resignation of Director and Appointment of New Director

LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...

Bayer and Sumitomo in Fungicides Collaboration

Bayer and Sumitomo Chemical have agreed to cooperate in developing new fungicides aimed at controlling soybean diseases in Brazil. Financial details of the partnership were not disclosed.

Sumitomo and BASF to develop new Fungicide

Japan’s Sumitomo Chemical and Germany’s BASF have joined forces to develop a novel fungicidal compound discovered by the Japanese partner and said to demonstrate “high efficacy&rdquo...

Savaria Announces 2017 Second Quarter Results Release Date

LAVAL, QUEBEC -- (Marketwired) -- 07/27/17 -- Savaria Corporation ("Savaria") (TSX: SIS), one of North America's leaders in the accessibility industry, will release its 2017 second quarter results a...

Intrinsic4D Inc. Announces Public Sale of Substantially all of the Assets of its Operating Subsidiary and Transfer to NEX

TORONTO, ONTARIO -- (Marketwired) -- 05/11/17 -- Intrinsic4D Inc. (the "Corporation") (TSX VENTURE: IFD) provides stakeholders with an update in relation to its financial status and solvency. Publi...

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 14062017] Prices from USD $350

Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sumitomo Dainippon Pharma Co., Ltd. Mergers Acquisitions MA, Partnershi...

PubMed Articles [652 Associated PubMed Articles listed on BioPortfolio]

The role of tramadol in pain management in Latin America: a report by the Change Pain Latin America Advisory Panel.

Change Pain Latin America (CPLA) was created to enhance chronic pain understanding and develop pain management improving strategies in this region. During its 7(th) meeting (August 2016), the main obj...

Organizational Issues, Structure, and Processes of Care in 257 ICUs in Latin America: A Study From the Latin America Intensive Care Network.

Latin America bears an important burden of critical care disease, yet the information about it is scarce. Our objective was to describe structure, organization, processes of care, and research activit...

Characteristics of seasonal influenza A and B in Latin America: Influenza surveillance data from ten countries.

The increased availability of influenza surveillance data in recent years justifies an actual and more complete overview of influenza epidemiology in Latin America. We compared the influenza surveilla...

Domestication and human demographic history in South America.

The early groups of hunter-gatherers who peopled South America faced significant ecological changes in their trophic niche for a relatively short period after the initial peopling. In particular, the ...

Embolic Stroke of Undetermined Source in Latin America: A Review.

Stroke is a major health concern throughout Latin America. As elsewhere, no precise cause can be determined for a substantial portion of strokes. In 6 studies since 2010 in the region, 16% to 43% of i...

Clinical Trials [300 Associated Clinical Trials listed on BioPortfolio]

Improving Perinatal Care in Latin America

Many obstetrical interventions used in Latin America, as in other parts of the world, have been shown to be ineffective or harmful, while effective interventions remain underutilized. This...

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

This trial is conducted in Africa, Asia, Europe, South America, and the United States of America (USA). The purpose of this study is to evaluate the effectiveness of secondary prophylacti...

Use of Activated Recombinant Human Factor VII in Cardiac Surgery

This trial is conducted in Africa, Asia, Europe, South America and the United States of America (USA). The trial is planned to investigate the safety and efficacy of NovoSeven® in the ma...

Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin

This trial will be conducted in Africa, Asia, North America and South America. The aim of this clinical trial is to compare NN1250 with sitagliptin, as add-on to subject's own current oral...

Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America

Ibandronate is a third-generation biphosphonate with recognized antiresorptive efficacy by several international, randomized, double-blind, controlled trials. These studies have not includ...

Companies [1064 Associated Companies listed on BioPortfolio]

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

Sumitomo Corporation of America (SCOA)

Sumitomo Corporation of America (SCOA) brings a global perspective to today's business opportunities as the largest subsidiary of Sumitomo Corporation (SC), one of Japan's major integrated trading and...

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Sumitomo Heavy Industries, Ltd.

Sumitomo Heavy Industries, Ltd. (TOKYO:6302) is a technology-oriented Japanese manufacturer of medical and industrial machinery. Its accelerator technology is widely used in the s...

Sumitomo Corporation Europe Limited

Sumitomo Corporation Europe is a principal subsidiary of Sumitomo Corporation, a leading integrated trading company with its headquarters in Japan, and as such we share in its key role in the exchange...

More Information about "Sumitomo Corporation of America" on BioPortfolio

We have published hundreds of Sumitomo Corporation of America news stories on BioPortfolio along with dozens of Sumitomo Corporation of America Clinical Trials and PubMed Articles about Sumitomo Corporation of America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sumitomo Corporation of America Companies in our database. You can also find out about relevant Sumitomo Corporation of America Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record